TransMedics Group Inc (TMDX) financials · rev $605.5M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
TransMedics Group Inc (TMDX) rev $605.5M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $605.5M | $441.5M |
| Cost of Revenue | $242.7M | $179.5M |
| Gross Profit | $362.8M | $262.1M |
| Operating Income | $108.6M | $37.5M |
| Net Income | $190.3M | $35.5M |
| EPS (Diluted) | $4.87 | $1.01 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $1.07B | $804.1M |
| Current Assets | $637.8M | $497.2M |
| Cash & Equivalents | $488.4M | $336.6M |
| Inventory | $48.9M | $46.6M |
| PP&E | $327.7M | $286.0M |
| Total Liabilities | $595.3M | $575.5M |
| Current Liabilities | $89.3M | $59.9M |
| Short-term Debt | $10.0M | N/A |
| Total Debt | $10.0M† | N/A |
| Shareholders' Equity | $473.1M | $228.6M |
| Retained Earnings | -$277.9M | -$468.2M |
† Total Debt: Derived from short-term debt only (no total or long-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $192.8M | $48.8M |
| CapEx | $59.3M | $129.7M |
| Investing Cash Flow | -$59.3M | -$129.3M |
| Financing Cash Flow | $16.9M | $22.9M |
| Net Change in Cash | $151.7M | -$58.2M |
| Free Cash Flow | $133.6M | -$80.9M |
FAQ
What is TMDX P/E and revenue?
TransMedics Group Inc (TMDX) rev $605.5M.
What is TMDX revenue?
TransMedics Group Inc last cached revenue is $605.5M (FY2025).
Is TMDX profitable?
TransMedics Group Inc last cached net income is $190.3M (FY2025).
What are TMDX total assets?
TransMedics Group Inc last cached total assets are $1.07B (FY2025).
What is TMDX free cash flow?
TransMedics Group Inc last cached free cash flow is $133.6M (FY2025).
Not investment advice. Cached statements, not a live tape.